Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,366 INR | +4.79% | +5.92% | +0.72% |
May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.72% | 1.24B | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India